<DOC>
	<DOCNO>NCT00621751</DOCNO>
	<brief_summary>The purpose study determine carbamazepine reduces irritability aggression among individual traumatic brain injury</brief_summary>
	<brief_title>Carbamazepine Treatment Chronic Post-Traumatic Brain Injury Irritability Aggression</brief_title>
	<detailed_description>It anticipate 74 subject 74 correspond subject informant recruit Carolinas Rehabilitation . Subjects recruit clinic Carolinas Rehabilitation . Subjects also refer psychiatrist North Carolina Neuropsychiatry . Subjects consent qualify randomized 1:1 ratio Tegretol® placebo . Stratification randomization group occur base presence depression define BDI-II score ≥ 13 . Subjects randomize active drug titrate dose , tolerate , period 3 week . Starting dose 200mg twice daily 200mg three time daily 200mg , 2 tab , twice daily . There 3 clinic visit . Visits occur baseline consent screening , day 28 , day 42 . Follow phone call occur week subject see clinic end study . Follow phone call assess study medication compliance , adverse event concomitant medication change . Day 42 end period Randomized Clinical Trial phase study subject begin 1 week taper Tegretol® 400mg daily stop drug . A safety phone call make day 49 . The following questionnaire use measure irritability subject informant : Neuropsychiatric Inventory ( NPI ) , State Trait Anger Expression Inventory ( STAXI-2 ) , Global Impression Change . The follow 3 questionnaire dispense subject : Beck Depression Inventory , Brief Symptom Inventory , Fatigue Impact Scale . The Investigator complete Clinical Global Impression change Visits 2 3 . History Physical Exam , hematology , chemistry , include renal liver function study obtain safety tolerability . Serum pregnancy test draw screen female childbearing potential . Carbamazepine level draw visit 2 3 .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Closed head injury ( define impair brain function result externally inflict trauma without penetrate injury ) least 6 month prior enrollment Age time enrollment : 16 75 year Voluntary inform consent patient informant Subject informant willing comply protocol Informantrated NPI Irritability Domain score 6 great include moderatesevere irritability Medically neurologically stable month prior enrollment If take antidepressant , anxiolytic , hypnotic , stimulant medication , change anticipate medication month prior enrollment No change therapy medication plan 42day participation No surgery plan 42day participation Vision , hearing , speech , motor function , comprehension sufficient compliance test procedure assessment Informant ( e.g . family member close friend ) daily interaction order observe occurrence irritability Potential subject without reliable informant Penetrating head injury Injury &lt; 6 month prior enrollment Ingestion CBZ month prior enrollment Inability interact sufficiently communication caregiver Acute rehabilitation record unavailable incomplete DSMIV diagnosis schizophrenia psychosis Diagnosis progressive additional neurologic disease Clinical sign active infection Creatinine clearance &lt; 60 mL/min Liver function test &gt; 2x normal value Pregnancy ( BetaHCG + females childbearing potential ) ; lactate female ; sexually active female agree use birth control Hormonal birth control mean birth control sexually active child bearing age potential due CBZ effect lower hormone level , potentially effectiveness Concurrent use follow medicine due potential drug interaction : macrolides , rifabutin , doxycycline , nicoumalone , warfarin , fluoxetine , fluvoxamine , viloxazine , nefazodone , tricyclic tetracyclic antidepressant , clobazam , clonazepam , lamotrigine , phenytoin , sodium valproate , tigabine topiramate , phenobarbitone , primidone , chloroquine mefloquine , antipsychotic , indinavir , nelfinavir , saquinavir , ritonavir , diltiazem , verapamil , felodipine , isradipine , nicardipine , nifedipine , cimetidine , cyclosporins , corticosteroid , gestrinone toremifene , danazol , tibolone Suicidal ideation Concurrent use Monoamine Oxidase Inhibitors ( MAOIs ) ingestion MOAI within 2 week start study Hypersensitivity/allergy CBZ , ingredient CBZ , structurally relate drug ( e.g . tricyclic antidepressant ) History liver failure hepatitis History renal failure History atrioventricular ( AV ) conduction abnormality unless paced History bone marrow depression History porphyria Asian heritage</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Brain Injury</keyword>
	<keyword>Irritability</keyword>
	<keyword>Aggression</keyword>
</DOC>